CD BioGlyco Launches Therapeutic Nucleic Acid Development Platform | #protein #technology
CD BioGlyco's Glycoprotein Enrichment Platform: Enabling Reliable Detection from Challenging Biological Samples | #health
CD BioGlyco is a sub-brand of CD Bio Group. We offer a full range of glycobiology-related products, analysis, custom synthesis, and design to advance your glycobiology research. We have provided professional and reliable scientific research assistance to customers from all over the world and received a lot of appreciation.
Quality and efficiency are our criteria to evaluate ourselves. Our experienced scientists provide quality services using a large number of advanced instruments. We do not subcontract services in order to guarantee high-quality standards.
